Development of the Indian OTC and Pharma market to 2035
India has a huge OTC and Pharma market and is amongst the biggest markets in the world. The exponential growth of this market may be worth considering for your business.
India is the largest provider of generic drugs globally. The Indian Consumer health and pharma sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of all medicine in the UK. Globally, India ranks 3rd in terms of self-medication and Rx production by volume and 14th by value. The domestic healthcare industry includes a network of more than 5,000 drug companies and ~10,500 manufacturing units. The OTC & Pharma Market should reach USD 48,7 Billion in 2035 in ex-factory, according to Chameleon Pharma Consulting Group forecasts.
Top OTC and pharma Companies in India in 2021
- Sun Pharmaceutical Industries
- Divi’s Laboratories
- Dr. Reddy’s Laboratories
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic OTC and pharma market is estimated at US$ 26,4 billion in 2021 and likely further expand to reach US$ 73 billion by 2035.
At Chameleon Pharma Consulting Group, we help European market entry for clients from Asia through consulting on Regulatory topics, GMP Certificates, and Market Entry Scenarios. Contact us for more details!
The Indian OTC and pharma market in 2035
USD 48,7 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
India in numbers
Interested in this market?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.